Page last updated: 2024-09-03

sb 200646 and sb 221284

sb 200646 has been researched along with sb 221284 in 1 studies

Compound Research Comparison

Studies
(sb 200646)
Trials
(sb 200646)
Recent Studies (post-2010)
(sb 200646)
Studies
(sb 221284)
Trials
(sb 221284)
Recent Studies (post-2010) (sb 221284)
24051003

Protein Interaction Comparison

ProteinTaxonomysb 200646 (IC50)sb 221284 (IC50)
Cytochrome P450 1A2Homo sapiens (human)0.013
Cytochrome P450 2D6Homo sapiens (human)0.11

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bristow, LJ; Duxon, MS; Hutson, PH; O'Connor, D; Watts, R1

Other Studies

1 other study(ies) available for sb 200646 and sb 221284

ArticleYear
Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
    Neuropharmacology, 2000, Apr-27, Volume: 39, Issue:7

    Topics: Animals; Behavior, Animal; Fluoxetine; Indoles; Male; Motor Activity; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Social Behavior; Urea

2000